Reduction of postoperative blood loss by local administration of 4dryField PH after duo-ear prosthesis implantation in patients with medial femoral neck fracture - a randomized controlled study
Not Applicable
- Conditions
- S72.01
- Registration Number
- DRKS00017452
- Lead Sponsor
- niversitätsklinik für Unfallchirurgie
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Patients with medial femoral neck fracture (Garden type III / IV) who are indicated for the implantation of a hemiprosthesis according to the valid standard
Exclusion Criteria
- polytraumatized patients
- presence of an injury to the ipsilateral limb
- Patients with tumor disease
- preoperative Hb <= 6 mmol / l
- known starch allergy
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method check the effect of the local hemostyptic 4DryField®PH on the postoperative blood loss after implantation of a duo head prosthesis<br>with medial femoral neck fracture.
- Secondary Outcome Measures
Name Time Method - Examination of the formation of a hematoma / seroma are examined sonographically<br>- 6 weeks postoperatively, check the function of the operated hip joint by means of functional test
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms does 4dryField PH utilize to reduce postoperative blood loss in medial femoral neck fracture patients?
How does local administration of 4dryField PH compare to standard hemostatic agents in duo-ear prosthesis implantation outcomes?
Are there specific biomarkers that identify patients with medial femoral neck fractures who will respond optimally to 4dryField PH treatment?
What adverse events are associated with 4dryField PH application during orthopedic surgery and how are they managed?
What other hemostatic compounds or combination therapies show promise for reducing postoperative bleeding in hip fracture repair?